179 related articles for article (PubMed ID: 21767237)
1. Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke.
Lukasik M; Dworacki G; Michalak S; Kufel-Grabowska J; Watala C; Kozubski W
Platelets; 2012; 23(2):132-42. PubMed ID: 21767237
[TBL] [Abstract][Full Text] [Related]
2. Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients.
Lukasik M; Dworacki G; Michalak S; Kufel-Grabowska J; Golanski J; Watala C; Kozubski W
Thromb Res; 2011 Nov; 128(5):e73-80. PubMed ID: 21788065
[TBL] [Abstract][Full Text] [Related]
3. Platelet and monocyte activation in acute ischemic stroke--is there a correlation with stroke etiology?
Oberheiden T; Nguyen XD; Fatar M; Elmas E; Blahak C; Morper N; Dempfle CE; Hennerici M; Borggrefe M; Kälsch T
Clin Appl Thromb Hemost; 2012; 18(1):87-91. PubMed ID: 21733938
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke.
Lukasik M; Dworacki G; Kufel-Grabowska J; Watala C; Kozubski W
Thromb Haemost; 2012 Feb; 107(2):346-55. PubMed ID: 22234746
[TBL] [Abstract][Full Text] [Related]
5. Reactive leptin resistance and the profile of platelet activation in acute ischaemic stroke patients.
Lukasik M; Michalak S; Dworacki G; Siewiera K; Kaczmarek M; Watala C; Kozubski W
Thromb Haemost; 2012 Jul; 108(1):107-18. PubMed ID: 22627503
[TBL] [Abstract][Full Text] [Related]
6. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Purdy G; Lawrie AS; Watt H; Brown MM; Machin SJ
Br J Haematol; 2004 Jun; 125(6):777-87. PubMed ID: 15180868
[TBL] [Abstract][Full Text] [Related]
7. Elevated platelet-monocyte complexes in patients with psoriatic arthritis.
Pamuk GE; Nuri Pamuk O; Orüm H; Arican O; Turgut B; Demir M
Platelets; 2009 Nov; 20(7):493-7. PubMed ID: 19852688
[TBL] [Abstract][Full Text] [Related]
8. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
Chung I; Choudhury A; Patel J; Lip GY
J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte-platelet aggregates in acute and subacute ischemic stroke.
Marquardt L; Anders C; Buggle F; Palm F; Hellstern P; Grau AJ
Cerebrovasc Dis; 2009; 28(3):276-82. PubMed ID: 19609079
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Choudhury A; Chung I; Panja N; Patel J; Lip GYH
Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
[TBL] [Abstract][Full Text] [Related]
12. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
13. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
15. The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke.
Pawelczyk M; Baj Z; Chmielewski H; Kaczorowska B; Klimek A
Cerebrovasc Dis; 2009; 27(2):131-7. PubMed ID: 19047793
[TBL] [Abstract][Full Text] [Related]
16. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke.
Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH
Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449
[TBL] [Abstract][Full Text] [Related]
17. Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet-leukocyte aggregate formation.
Ayukawa O; Nakamura K; Kariyazono H; Ikeda R; Arima J; Shinkawa T; Iwase H; Sakata R; Yamada K
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):176-84. PubMed ID: 19300046
[TBL] [Abstract][Full Text] [Related]
18. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation.
Kälsch T; Elmas E; Nguyen XD; Suvajac N; Klüter H; Borggrefe M; Dempfle CE
Basic Res Cardiol; 2007 Sep; 102(5):460-6. PubMed ID: 17624488
[TBL] [Abstract][Full Text] [Related]
20. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
